HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Acute Promyelocytic Leukemia

An acute myeloid leukemia in which abnormal PROMYELOCYTES predominate. It is frequently associated with DISSEMINATED INTRAVASCULAR COAGULATION.
Also Known As:
Leukemia, Promyelocytic, Acute; AML M3; Leukemia, Acute Promyelocytic; M3 ANLL; ANLL, M3; Acute Promyelocytic Leukemias; Leukemia, Myeloid, Acute, M3; Leukemia, Progranulocytic; Myeloid Leukemia, Acute, M3; Progranulocytic Leukemia; Promyelocytic Leukemia, Acute
Networked: 4894 relevant articles (700 outcomes, 435 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. Neoplasms (Cancer)
2. Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
3. Leukemia
4. Residual Neoplasm
5. Hematologic Neoplasms (Hematological Malignancy)

Experts

1. Tallman, Martin S: 58 articles (01/2022 - 01/2002)
2. Lo-Coco, Francesco: 56 articles (10/2020 - 10/2002)
3. Sanz, Miguel A: 50 articles (01/2021 - 02/2004)
4. Chen, Zhu: 43 articles (05/2021 - 06/2000)
5. Zhou, Jin: 39 articles (12/2021 - 11/2003)
6. Ravandi, Farhad: 33 articles (01/2022 - 02/2004)
7. de Thé, Hugues: 32 articles (01/2022 - 06/2003)
8. Breccia, Massimo: 30 articles (11/2021 - 02/2002)
9. Chen, Sai-Juan: 30 articles (01/2021 - 02/2002)
10. Montesinos, Pau: 29 articles (01/2021 - 01/2007)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Acute Promyelocytic Leukemia:
1. Tretinoin (Retinoic Acid)FDA LinkGeneric
2. Arsenic Trioxide (Trisenox)FDA Link
3. Aligeron (AS 2)IBA
4. ArsenicIBA
5. AnthracyclinesIBA
6. RetinoidsIBA
7. promyelocytic leukemia-retinoic acid receptor alpha fusion oncoproteinIBA
8. Cytarabine (Cytosar-U)FDA LinkGeneric
9. Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric
10. Retinoic Acid Receptor alphaIBA

Therapies and Procedures

1. Therapeutics
2. Drug Therapy (Chemotherapy)
3. Aftercare (After-Treatment)
4. Remission Induction
5. Stem Cell Transplantation